CARY, N.C.--(BUSINESS WIRE)--The CEO Roundtable on Cancer has accredited LEERINK Partners LLC in Boston, MA with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
“LEERINK is honored to receive the CEO Cancer Gold StandardTM accreditation and be recognized for our efforts in fostering workplace wellness,” said Jeff Leerink, Chairman and CEO of LEERINK Partners. “As a healthcare investment bank, promoting health and wellness education and initiatives lie at the core of our business.”
The CEO Roundtable on Cancer, a nonprofit organization of CEOs, founded by former President George H.W. Bush, developed and administers the Gold Standard, a workplace accreditation program which encourages and recognizes the commitment of organizations that take concrete actions to address cancer in their workplaces. Over 200 private, nonprofit and government employers in a wide range of industries have earned Gold Standard accreditation, including the National Cancer Institute (NCI) and a number of NCI-designated cancer centers.
To earn Gold Standard accreditation, an employer must establish programs to reduce cancer risk by taking concrete actions in five key areas: establishing policies and programs to reduce cancer risk by prohibiting tobacco use and supporting tobacco cessation efforts; promoting physical activity, healthy nutrition and weight management; providing health insurance options that include detecting cancer at its earliest stages, access to quality care and participation in cancer clinical trials; promoting employee awareness of these initiatives; and supporting the needs of cancer survivors in the workplace.
“LEERINK Partners is leading by example in promoting healthier behavior,” said Robert A. Bradway, Chairman and Chief Executive officer of Amgen and Chairman of the CEO Roundtable on Cancer. “I hope their vision and commitment to better health will encourage other employers in MA and across all industries and geographies to become Gold Standard accredited.”
In addition to NCI and the Centers for Disease Control and Prevention, 16 NCI-designated cancer centers and more than 200 employers have earned Gold Standard accreditation. CEOs from many industries are keenly aware of the life-improving impact they can have on health and controlling healthcare costs when they address cancer and other chronic diseases. Gold Standard employers include: Amgen, Avis Budget Group, CVS Health, Dell, Harvard T.H. Chan School of Public Health, Lowe’s, State Farm, The Ohio State University, Johnson & Johnson, Novartis, SAS and many Blue Cross affiliates.
About LEERINK Partners LLC
LEERINK Partners LLC is a leading investment bank, specializing in healthcare. Our knowledge, experience and focus enable us to help our clients define and achieve their strategic, capital markets and investment objectives. We partner with companies that develop and commercialize innovative products and services that are defining the future of healthcare. LEERINK Partners LLC is a member of FINRA/SIPC. For more information, please visit: www.leerink.com.
About The CEO Roundtable on Cancer
The CEO Roundtable on Cancer was founded in 2001, when former President George H.W. Bush challenged a group of executives to "do something bold and venturesome about cancer within your own corporate families." The CEOs responded by creating and encouraging the widespread adoption of the CEO Cancer Gold Standard™ which calls for organizations to evaluate their health benefits and workplace culture and take extensive, concrete actions in five key areas of health and wellness to address cancer in the workplace. For more information on the CEO Cancer Gold Standard and the free web-based accreditation process, please visit www.CancerGoldStandard.org.